Transmitting information to us by e-mail unilaterally does not establish an attorney-client relationship or impose an obligation on either the law firm or even the receiving lawyer to keep the transmitted information confidential. By clicking "OK", you acknowledge that we have no obligation to maintain the confidentiality of any information you submit to us unless we already represent you or unless we have agreed to receive limited confidential material/information from you as a prospective client. Thus, if you are not a client or someone we have agreed to consider as a prospective client, information you submit to us by e-mail may be disclosed to others or used against you. If you would like to discuss becoming a client, please contact one of our attorneys to arrange for a meeting or telephone conference. If you wish to disclose confidential information to a lawyer in the firm before an attorney-client relationship is established, the protections that the law firm will provide to such information from a prospective client should be discussed before such information is submitted. Thank you for your interest in Goodwin Procter.

main

Understanding the Intellectual Property Lic

Understanding the Intellectual Property License 2016 

Understanding the Intellectual Property License 2016

Summary

Related Content

NLRB Concludes that Separation Agreement Provisions Prohibiting Disparagement and Requiring Confidentiality of Agreement Terms Violate Employee Rights

Cannabis Marketing Proposed Regulations in New York & Neighboring States (Bloomberg Law)

FTC Proposes a Sweeping Rule That Would Ban Nearly All US Noncompete Agreements

3 Reasons Beauty Cos. Should Consider Pursuing Patents

Recent Court Decisions Shed Light on Enforceability of Electronic Contracts in the U.S.

Chief Judge of Western District of Texas Changes Waco Patent Case Assignment System

Fintiv 2.0: USPTO Director Issues Guidance Softening Risk of Discretionary Denial

U.S. Government Authorizes Transactions Related to Patent Protection in Russia

Reactions to Amgen v. Sanofi and the Future of Patent Law’s Enablement Requirement

USC Gould School of Law's 2023 Intellectual Property Institute

Goodwin Welcomes Leading Technology and Life Sciences Litigation Team in New York

Goodwin Welcomes Partner Group of IP Litigators (The American Lawyer)

OncoC4 Announces Strategic Collaboration with BioNTech to Co-Develop and Commercialize Novel Checkpoint Antibody in Multiple Solid Tumor Indications

Redpoint Ventures Leads Zed’s $10 Million Series A

Storage Solutions Acquired by Jungheinrich

Goodwin Represents Mirion Technologies in $85.6 Million Debut Secondary Offering

Intellectual Property